Caixin

China Tops World in Chronic Kidney Disease Cases, Study Shows

Published: Nov. 20, 2025  5:15 p.m.  GMT+8
00:00
00:00/00:00
Listen to this article 1x
The global burden of chronic kidney disease attributable to different risk factors for different age groups in 2023.
The global burden of chronic kidney disease attributable to different risk factors for different age groups in 2023.

Global cases of chronic kidney disease have accelerated to approximately 788 million, with China accounting for the largest single population of patients, according to a new study published in The Lancet.

The research estimates that the number of adults aged 20 and older living with the condition globally reached 788 million in 2023, a significant jump from 378 million in 1990. The disease has now become the ninth leading cause of death worldwide, driven largely by rising rates of high blood sugar, hypertension and obesity.

These findings highlight a rapidly expanding global health crisis characterized by high mortality and low public awareness, creating an urgent challenge for health systems where only a fraction of end-stage patients currently receive adequate life-saving treatment.

loadingImg
You've accessed an article available only to subscribers
VIEW OPTIONS

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Disclaimer
This is an AI-generated English rendering of original reporting or commentary published by Caixin Media. In the event of any discrepancies, the Chinese version shall prevail.
Share this article
Open WeChat and scan the QR code
DIGEST HUB
Digest Hub Back
Explore the story in 30 seconds
  • Global chronic kidney disease cases reached 788 million in 2023, up from 378 million in 1990; China leads with 152 million cases.
  • The disease is now the ninth leading cause of death worldwide, causing 1.48 million deaths in 2023 and contributing to 11.5% of all cardiovascular deaths.
  • Only 20% of end-stage patients receive adequate treatment; WHO recognized kidney disease as a priority, urging expanded screening and low-cost therapies.
AI generated, for reference only
Subscribe to unlock Digest Hub
SUBSCRIBE NOW
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Chinese Local Governments Risk Replicating Mistakes of LGFVs
00:00
00:00/00:00